406 related articles for article (PubMed ID: 31922266)
1. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011659. PubMed ID: 31922266
[TBL] [Abstract][Full Text] [Related]
2. Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gana JC; Cifuentes LI; Gattini D; Torres-Robles R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011803. PubMed ID: 33164205
[TBL] [Abstract][Full Text] [Related]
3. Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gana JC; Cifuentes LI; Gattini D; Villarroel Del Pino LA; Peña A; Torres-Robles R
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010546. PubMed ID: 31550050
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011973. PubMed ID: 33498095
[TBL] [Abstract][Full Text] [Related]
5. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.
Ríos Castellanos E; Seron P; Gisbert JP; Bonfill Cosp X
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010180. PubMed ID: 25966446
[TBL] [Abstract][Full Text] [Related]
10. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
Vadera S; Yong CWK; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
[TBL] [Abstract][Full Text] [Related]
11. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Roberts D; Best LM; Freeman SC; Sutton AJ; Cooper NJ; Arunan S; Begum T; Williams NR; Walshaw D; Milne EJ; Tapp M; Csenar M; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013155. PubMed ID: 33837526
[TBL] [Abstract][Full Text] [Related]
12. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.
Gluud LL; Krag A
Cochrane Database Syst Rev; 2012 Aug; (8):CD004544. PubMed ID: 22895942
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
14. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
Colli A; Gana JC; Yap J; Adams-Webber T; Rashkovan N; Ling SC; Casazza G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008759. PubMed ID: 28444987
[TBL] [Abstract][Full Text] [Related]
15. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
16. Medical prophylaxis of haemorrhage from oesophageal varices in patients with liver cirrhosis.
Gross M; Zoller WG
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):603-12. PubMed ID: 9222734
[TBL] [Abstract][Full Text] [Related]
17. Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
Colli A; Gana JC; Turner D; Yap J; Adams-Webber T; Ling SC; Casazza G
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008760. PubMed ID: 25271409
[TBL] [Abstract][Full Text] [Related]
18. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
19. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
D'Amico G; Pagliaro L; Pietrosi G; Tarantino I
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD002233. PubMed ID: 20238318
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
Zoller WG; Gross M
Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]